Network Ad
💫 Pop Pulse — Celebrity gossip & entertainment Explore
Loading...
Happy 30% Chaos 20% Sad 10% Well 50% Anger 10% Fear 5% Surprise 40%
» Biotech » Permalink » Source
0

Longevity biotech seeks to broaden its therapeutic capabilities with cellular reprogramming and delivery technologies. UPDATE: On October 7th, 2025, Klotho Neurosciences announced that its Letter of Intent to acquire assets from Turn Biotechnologies was allowed to expire. The company said its Board of Directors decided that the proposed transaction “did not fit its long-term strategic […] The post Klotho Neuro moves to acquire Turn Bio assets appeared first on Longevity.Technology.

(0) Comments 0 💬
More in Biotech →
Be respectful and constructive. Comments are moderated.

No comments yet.